U.S. AstraZeneca vaccine trial will clear confusion on how well it works -U.S. scientist

A top U.S. scientist overseeing COVID-19 vaccine trials expects a large U.S. study to determine how effective AstraZeneca's experimental inoculation is, following perplexing results from other trials ...

Gloomy COVID drug data shows why big, randomised trials matter

When it comes to trials of any drug, size matters, potentially giving the World Health Organization's (WHO) gloomy verdict on Gilead Sciences' COVID-19 treatment remdesivir an edge over the company's ...
The Lancet

Evidence without evolution: a call for precision behavioural therapy in irritable bowel syndrome

In The Lancet Gastroenterology & Hepatology, Elyse Thakur and colleagues1 present an update of their 2020 systematic review and network meta-analysis on the efficacy of behavioural therapies for ...